Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018

20201,423 citationsJournal Articlehybrid Open Access

Authors

Olivier J. Wouters · London School of Economics and Political Science

Martin McKee · London School of Hygiene & Tropical Medicine

Abstract

This study provides an estimate of research and development costs for new therapeutic agents based on publicly available data. Differences from previous studies may reflect the spectrum of products analyzed, the restricted availability of data in the public domain, and differences in underlying assumptions in the cost calculations.

Topics & Keywords

Pharmaceutical Economics and Policy Health Systems, Economic Evaluations, Quality of Life Biosimilars and Bioanalytical Methods

UN Sustainable Development Goals

Partnerships for the goals

Publication Details

Published in: JAMA

Volume 323, Issue 9, pp. 844-844

DOI: 10.1001/jama.2020.1166

Field-Weighted Citation Impact: 253.57